- Sponsored Content
- Bioreactors
- Gene Therapies
Industrialize Your Viral Vector Production in Adherent and Suspension Cell Cultures: Know the Pros and ConsIndustrialize Your Viral Vector Production in Adherent and Suspension Cell Cultures: Know the Pros and Cons
1 Min Read
Sponsored by Cytiva
This educational podcast, “The Evolution of Culture Systems for Viral Vector Production: Advantages, Challenges and Cost Considerations,” recently published by Cell and Gene Therapy Insights, discusses in detail the pros and cons of viral vector production in adherent and suspension cell culture.
This special report illustrates how Pall Biotech’s iCELLis 500+ bioreactors and Allegro STR bioreactors can bolster adherent and suspension culture, respectively, for viral vector production. Fill out the form below to read the complete report and learn more now.
Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
You May Also Like